This is a preview of subscription content, log in via an institution to check access.
Notes
The study was funded by GlaxoSmithKline Biologicals SA.
Reference
Akpo EIH, et al. Epidemiological impact and cost-effectiveness of varicella vaccination strategies in the United Kingdom (UK). Clinical Infectious Diseases : 11 Nov 2020. Available from: URL: http://doi.org/10.1093/cid/ciaa1708
Rights and permissions
About this article
Cite this article
Is childhood universal varicella vaccination cost effective in the UK?. PharmacoEcon Outcomes News 867, 25 (2020). https://doi.org/10.1007/s40274-020-7322-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7322-3